Computational study of the putative active form of protein Z (PZa): Sequence design and structural modeling

Although protein Z (PZ) has a domain arrangement similar to the essential coagulation proteins FVII, FIX, FX, and protein C, its serine protease (SP)‐like domain is incomplete and does not exhibit proteolytic activity. We have generated a trial sequence of putative activated protein Z (PZa) by identifying amino acid mutations in the SP‐like domain that might reasonably resurrect the serine protease catalytic activity of PZ. The structure of the activated form was then modeled based on the proposed sequence using homology modeling and solvent‐equilibrated molecular dynamics simulations. In silico docking of inhibitors of FVIIa and FXa to the putative active site of equilibrated PZa, along with structural comparison with its homologous proteins, suggest that the designed PZa can possibly act as a serine protease.

[1]  R. Doolittle,et al.  Genomic Evidence for a Simpler Clotting Scheme in Jawless Vertebrates , 2008, Journal of Molecular Evolution.

[2]  E. Ortlund,et al.  Crystal Structure of an Ancient Protein: Evolution by Conformational Epistasis , 2007, Science.

[3]  L. Pedersen,et al.  A proposed structural model of human protein Z , 2007, Journal of thrombosis and haemostasis : JTH.

[4]  D. Banner,et al.  Dose-dependent antithrombotic activity of an orally active tissue factor/factor VIIa inhibitor without concomitant enhancement of bleeding propensity. , 2006, Bioorganic & medicinal chemistry.

[5]  F. Rosendaal,et al.  Protein Z and protein Z-dependent protease inhibitor , 2005, Thrombosis and Haemostasis.

[6]  J. McVey,et al.  450 million years of hemostasis , 2003, Journal of thrombosis and haemostasis : JTH.

[7]  L. Hedstrom.  Serine protease mechanism and specificity. , 2002, Chemical reviews.

[8]  M. Krem,et al.  Evolution of enzyme cascades from embryonic development to blood coagulation. , 2002, Trends in biochemical sciences.

[9]  D. Agard,et al.  Enzyme specificity under dynamic control II: Principal component analysis of α‐lytic protease using global and local solvent boundary conditions , 2001, Protein science : a publication of the Protein Society.

[10]  M. Krem,et al.  Molecular markers of serine protease evolution , 2001, The EMBO journal.

[11]  G. Broze,et al.  Protein Z Circulates in Plasma in a Complex with Protein Z-Dependent Protease Inhibitor , 2001, Thrombosis and Haemostasis.

[12]  K. Harlos,et al.  Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla). , 1999, Journal of structural biology.

[13]  R. Huber,et al.  Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate binding. , 1999, Structure.

[14]  A M Brzozowski,et al.  Structure of human factor VIIa and its implications for the triggering of blood coagulation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Otlewski,et al.  Structural and energetic determinants of the S1-site specificity in serine proteases. , 1999, European journal of biochemistry.

[16]  David A. Agard,et al.  Enzyme specificity under dynamic control: A normal mode analysis of α-lytic protease , 1999 .

[17]  X. Han,et al.  Isolation of a protein Z-dependent plasma protease inhibitor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Sung-Hou Kim,et al.  Structural basis for chemical inhibition of human blood coagulation factor Xa. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Agard,et al.  Relationship between enzyme specificity and the backbone dynamics of free and inhibited alpha-lytic protease. , 1998, Biochemistry.

[20]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[21]  C. Craik,et al.  Evolutionary Divergence of Substrate Specificity within the Chymotrypsin-like Serine Protease Fold* , 1997, The Journal of Biological Chemistry.

[22]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.

[23]  S Foundling,et al.  The 2.8 A crystal structure of Gla‐domainless activated protein C. , 1996, The EMBO journal.

[24]  David W. Banner,et al.  The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor , 1996, Nature.

[25]  C. Post,et al.  Reexamination of induced fit as a determinant of substrate specificity in enzymatic reactions. , 1995, Biochemistry.

[26]  T. Darden,et al.  A smooth particle mesh Ewald method , 1995 .

[27]  M. Karplus,et al.  Evaluation of comparative protein modeling by MODELLER , 1995, Proteins.

[28]  C. Craik,et al.  Structural basis of substrate specificity in the serine proteases , 1995, Protein science : a publication of the Protein Society.

[29]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[30]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[31]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[32]  W. Rutter,et al.  Converting trypsin to chymotrypsin: the role of surface loops. , 1992, Science.

[33]  D. Eisenberg,et al.  Assessment of protein models with three-dimensional profiles , 1992, Nature.

[34]  D. Eisenberg,et al.  A method to identify protein sequences that fold into a known three-dimensional structure. , 1991, Science.

[35]  W. Kisiel,et al.  Amino acid sequence of human protein Z, a vitamin K-dependent plasma glycoprotein. , 1990, Biochemical and Biophysical Research Communications - BBRC.

[36]  J. Nishioka,et al.  Primary structure of vitamin K-dependent human protein Z. , 1990, Biochemical and biophysical research communications.

[37]  J. Miletich,et al.  Human plasma protein Z antigen: range in normal subjects and effect of warfarin therapy. , 1987, Blood.

[38]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .